266 related articles for article (PubMed ID: 1172906)
1. Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, testosterone, and seminal fluid analyses in normal men.
Mauss J; Börsch G; Bormacher K; Richter E; Leyendecker G; Nocke W
Acta Endocrinol (Copenh); 1975 Feb; 78(2):373-84. PubMed ID: 1172906
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
3. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
4. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
5. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
6. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
Soufir JC; Jouannet P; Marson J; Soumah A
Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
[TBL] [Abstract][Full Text] [Related]
7. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
[TBL] [Abstract][Full Text] [Related]
8. Testicular function in a birth cohort of young men.
Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control.
Føgh M; Corker CS; McLean H; Hunter WM; Petersen IB; Philip J; Schou G; Skakkebaek NE
Acta Endocrinol (Copenh); 1980 Oct; 95(2):251-7. PubMed ID: 6776755
[TBL] [Abstract][Full Text] [Related]
10. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male.
Lübbert H; Leo-Rossberg I; Hammerstein J
Fertil Steril; 1992 Sep; 58(3):603-8. PubMed ID: 1387850
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men.
Morse HC; Leach DR; Rowley MJ; Heller CG
J Reprod Fertil; 1973 Mar; 32(3):365-78. PubMed ID: 4692335
[No Abstract] [Full Text] [Related]
12. Investigations on the use of testosterone oenanthate as a male contraceptive agent.
Mauss J; Börsch G; Richter E; Bormacher K
Contraception; 1974 Sep; 10(3):281-9. PubMed ID: 4374338
[TBL] [Abstract][Full Text] [Related]
13. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
[TBL] [Abstract][Full Text] [Related]
14. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
Føgh M; Corker CS; Hunter WM; McLean H; Philip J; Schou G; Skakkebaek NE
Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
[TBL] [Abstract][Full Text] [Related]
15. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
16. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
17. Effect of administration of a single dose of testosterone oenanthate on constituents of human seminal plasma and serum gonadotropins.
Sheth AR; Jayatilak PG; Thakur AN; Mugatwala P; Pardanani DS
Andrologia; 1976; 8(3):259-64. PubMed ID: 999044
[TBL] [Abstract][Full Text] [Related]
18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
19. Increased serum FSH levels correlated with low and high sperm counts in male infertile patients.
Sina D; Schuhmann R; Abraham R; Taubert HD; Dericks-Tan JS
Andrologia; 1975; 7(1):31-7. PubMed ID: 1163822
[TBL] [Abstract][Full Text] [Related]
20. The control of male fertility by 1,2,3-trihydroxypropane (THP;glycerol): rapid arrest of spermatogenesis without altering libido, accessory organs, gonadal steroidogenesis, and serum testosterone, LH and FSH.
Wiebe JP; Barr KJ
Contraception; 1984 Mar; 29(3):291-302. PubMed ID: 6428807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
